Histological Benefit of Retreatment by Pegylated Interferon Alfa-2b and Ribavirin in Patients with Recurrent Hepatitis C Virus Infection Posttransplantation
Titel:
Histological Benefit of Retreatment by Pegylated Interferon Alfa-2b and Ribavirin in Patients with Recurrent Hepatitis C Virus Infection Posttransplantation
Auteur:
Bizollon, T. Pradat, P. Mabrut, J.-Y. Radenne, S. Ducerf, C. Baulieux, J. Souquet, J. C. Trepo, C.